In the News
Enveric Biosciences signs licensing agreement with Diverse Biotech [Pharmaceutical Business Review]
Enveric Biosciences signs licensing agreement with Diverse Biotech
CBD-focused Enveric Biosciences Stock Soars on Heavy Volume After License Deal with Cancer Treatment Company [Market Watch]
https://www.marketwatch.com/story/cbd-focused-enveric-biosciences-stock-soars-on-heavy-volume-after-license-deal-with-cancer-treatment-company-2021-03-10
Enveric Biosciences Stock Skyrockets After Licensing Agreement With Diverse Biotech [Benzinga]
https://www.benzinga.com/general/biotech/21/03/20098291/enveric-biosciences-stock-skyrockets-after-licensing-agreement-with-diverse-biotech
Rising High: An Exclusive Talk with Biotech Company Enveric Biosciences [The Fly]
https://thefly.com/landingPageNews.php?id=3246224
Cannabis Stocks Rally Anew as $7 Billion GW Pharma Deal Spurs Interest in Weed and its Medical Benefits [Market Watch]
https://www.marketwatch.com/story/cannabis-stocks-rally-anew-as-7-billion-gw-pharma-deal-spurs-interest-in-weed-and-its-medical-benefits-11612376529
Jazz Leaps into Epilepsy with $7.2B Buyout of Cannabinoid Drugmaker GW Pharma [Fierce Pharma]
https://www.fiercepharma.com/pharma/jazz-eyes-epilepsy-market-7-2b-buyout-cannabinoid-drugmaker-gw
Cannabis Executives Reveal The Industry’s 2019 Challenges And A Few Opportunities Too
https://www.forbes.com/sites/julieweed/2019/02/19/cannabis-executives-reveal-the-industrys-2019-challenges-and-a-few-opportunities-too/?sh=edf941135caf